Internal Medicine, Medical Oncology · La Jolla, CA
NPI
1306909791
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3855 Health Sciences Dr # 987
La Jolla, CA, 92093
Phone (858) 822-5182
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
655 services
Medicare patients, 2024
104
Average age 74
Drug cost, 2024
$1.7M
331 prescriptions
Company payments, 2025
$55.69
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn A Gold was code 99215 (office e&m - established), 239 times for 53 patients. In total Kathryn A Gold billed 655 services in 9 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 239 | 53 | $111.51 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 229 | 43 | $13.06 | $2,990 |
| 99214 Office E&M - Established | Facility | 75 | 45 | $71.46 | $5,359 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 28 | 18 | $12.99 | $364 |
| 99215 Office E&M - Established | Office | 27 | 16 | $150.55 | $4,065 |
| 99214 Office E&M - Established | Office | 26 | 17 | $104.97 | $2,729 |
| 99205 Office E&M - New | Facility | 18 | 18 | $141.34 | $2,544 |
By year: 2022 $65K for 620 services; 2023 $56K for 555 services; 2024 $46K for 655 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn A Gold prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 62 prescriptions and refills. In total Kathryn A Gold wrote 331 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 62 | 62 | Under 11 | $918K |
| Levothyroxine Sodium Generic | 28 | 67 | Under 11 | $251 |
| Lorbrena Lorlatinib | 23 | 23 | Under 11 | $446K |
| Ondansetron Hcl Generic | 17 | 17 | 13 | $152 |
| Prochlorperazine Maleate Generic | 17 | 17 | 12 | $282 |
| Clindamycin Phosphate Generic | 13 | 17 | Under 11 | $1,021 |
| Dexamethasone Generic | 13 | 15 | Under 11 | $222 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 13 | 13 | Under 11 | $182 |
| Olanzapine Generic | 13 | 15 | Under 11 | $223 |
| Tabrecta Capmatinib Hydrochloride | 11 | 11 | Under 11 | $168K |
Brand drugs: - claims; generic drugs: 198 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn A Gold $55.69 ($55.69 in general payments such as food, travel and fees) from 3 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $55.69.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $55.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.